Eli Lilly | LLY - Eps Gewinn Pro Aktie

Aktienkurs
896.61
Täglich Wechseln
-19.70 -2.15%
Monatlich
-14.77%
Jährlich
9.12%
Q1 Prognose
888.93

Fiscal Kalender Aktuell Konsens Zuletzt Datum
FY2026Q1 Mar/2026 7.25 3.34 Apr/30
FY2025Q4 Dec/2025 7.54 7.16 5.32 Feb/04
FY2025Q3 Sep/2025 7.02 6.36 1.18 Oct/30
FY2025Q2 Jun/2025 6.31 5.55 3.92 Aug/07
FY2025Q1 Mar/2025 3.34 4.71 2.58 May/01




Eps Veränderung Datum
AbbVie USD 2.71 0.85 2025-12
Abbott USD 1.5 0.2 2025-12
ALKERMES USD 0.29 0.2 2025-12
Amgen USD 5.29 0.35 2025-12
AstraZeneca USD 2.12 0.26 2025-12
Baxter International USD 0.44 0.25 2025-12
Biogen USD 1.99 2.82 2025-12
Bristol-Myers Squibb USD 1.26 0.37 2025-12
Coherus Biosciences USD -0.43 0.06 2025-12
Drreddys Laboratories INR 0.16 0.04 2025-12
Eli Lilly USD 7.54 0.52 2025-12
Gilead Sciences USD 1.86 0.61 2025-12
GlaxoSmithKline GBP 0.26 0.29 2025-12
Glaxosmithkline GBP 0.21 0.51 2025-12
J&J USD 2.46 0.34 2025-12
Medtronic USD 1.36 0.29 2026-01
Merck USD 2.04 0.54 2025-12
Neurocrine Biosciences USD 1.88 0.29 2025-12
Novartis USD 1.54 0.5 2025-12
Novartis USD 1.54 0.48 2025-12
Novo Nordisk DKK 6.04 1.54 2025-12
Perrigo USD 0.77 0.03 2025-12
Pfizer USD 0.66 0.21 2025-12
Phibro Animal Health USD 0.78 0.1 2025-12
Prestige Brands USD 1.14 0.07 2025-12
Regeneron Pharmaceuticals USD 11.44 0.39 2025-12
Roche Holding CHF 8.37 2.95 2025-12
Sanofi EUR 1.53 1.38 2025-12
Sanofi EUR -0.67 3.62 2025-12
United Therapeutics USD 7.7 0.54 2025-12
Zoetis USD 1.48 0.22 2025-12